Home / News / Press Releases
News & Updates— Press Releases

News & Updates Press Releases

Veos Pharmaceuticals Selected to Present at Europe–Japan SALON Part 4, Showcasing OliQuell™ for Green Innovation.

Back to all press releases
Event August 21, 2025 Madrid, Spain

Veos Pharmaceuticals Selected to Present at Europe–Japan SALON Part 4, Showcasing OliQuell™ for Green Innovation

Veos to present its breakthrough olive-waste-derived platform at Tokyo event organized by SAKURA DEEPTECH Shibuya and the EU–Japan Centre for Industrial Cooperation.

Madrid, Spain — August 21, 2025 — Veos Pharmaceuticals is proud to announce its selection to present at the Europe–Japan SALON Part 4, organized by SAKURA DEEPTECH Shibuya and the EU–Japan Centre for Industrial Cooperation, under the EU Business Hub. The event will be held in Tokyo, Japan, on September 3, 2025, and will bring together leading European and Japanese startups, corporates, and policymakers with a focus on GREEN innovation.

OliQuell™ — Nature-Based Green Solutions

Veos Pharma will present OliQuell™, its breakthrough, nature-based platform derived from olive waste that provides scalable solutions for:

–84%
Methane
reduction
–81%
Hydrogen sulfide
reduction
–50%
CO₂
reduction

With proven results in Europe, Africa, and Asia, OliQuell™ aligns with Japan's GX 2030 decarbonization goals, offering a circular, chemical-free, and cost-effective alternative to traditional filtration and chemical flocculants.

"We are honored to bring Mediterranean innovation to Japan's stage at Europe–Japan SALON. OliQuell™ demonstrates how nature-based solutions can drive water security, clean air, and industrial sustainability in line with Japan's green transition goals." — Dr. Bassam Damaj, CEO of Veos Pharmaceuticals

Building Strategic Partnerships in Japan

Veos Pharmaceuticals looks forward to building strategic partnerships in Japan across the water, biogas, and filtration sectors to support sustainable growth and cross-border collaboration.

Event Details

📅 Date: September 3, 2025
📍 Location: Tokyo, Japan
🕔 Time: 5:00–7:30 PM JST

About Veos Pharmaceuticals

Headquartered in Madrid, Spain, Veos Pharmaceuticals S.L. is a global biotechnology company with a portfolio of nearly 40 products across the EU, US, and Canada. The company specializes in OTC solutions, biostimulants, and advanced nutritional products aimed at improving quality of life.

Veos Pharma's flagship products include Ocufresh®, BioPropello™, OliQuell™, OleoSorb™, VEOX-Preserve™, and ThymoTropin™.

For more information, visit www.veospharma.com.

Share: in 𝕏 @

Media & Investor Contact

Veos Pharmaceuticals, S.L.
Calle Núñez de Balboa, 35 A-5 Planta Oficina A1
28001 Madrid, Spain
Email: info@veospharma.com
Telephone: +34 911 925 649
Website: www.veospharma.com

Forward-Looking Statements. This announcement may include forward-looking statements based on current expectations and involving risks and uncertainties. Actual results may differ materially. Veos Pharmaceuticals assumes no obligation to update or revise these statements after the date of publication.